In both of our trials, we incorporate measures to assess not only whether GLP-1 agonists work, but also examine how they work via interrogating the hypothesized mechanisms, she told Freethink, adding that they anticipate having trial results in about 2-3 years
Further, because the only large-scale trials of GLP-1 agonists have been conducted in obese or overweight study populations, we dont yet know if these drugs affect body composition in normal-weight individuals in an equivalent manner
If you're unsure how much protein you should be consuming or what sources are best for you, it may be helpful to consult with a healthcare professional or nutritionist
Drug-induced cutaneous reactions: a report from the Boston collaborative drug surveillance program on 15 438 consecutive inpatients, 1975 to 1982
Feb 2005;6(1):15-22
Scheduling: Semax injected in the morning